Glaxo Reports Positive Data For ViiV Healthcare's FLAIR HIV Study
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that ViiV Healthcare's FLAIR study met its primary endpoint, reporting "positive headline results".ViiV is a HIV by - Read More